Appendiceal Cancers
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers (NCT07060014) | The Methodist Hospital Research Institute | 2025-07-18 |
| An International Study on Pediatric Patients With Rare Tumors. (NCT07072143) | Azienda Ospedaliera di Padova | 2025-01-25 |
Track Appendiceal Cancers automatically
Every clearance here is in the API, with alerts when new ones post.